Cardinal Health (NYSE:CAH) Releases FY 2025 Earnings Guidance

Cardinal Health (NYSE:CAH) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 7.550-7.700 for the period, compared to the consensus estimate of 7.530. The company issued revenue guidance of $215.1 billion-$219.7 billion, compared to the consensus revenue estimate of $209.8 billion. Cardinal Health also updated its FY25 guidance to $7.55-7.70 EPS.

Cardinal Health Stock Performance

CAH opened at $107.90 on Friday. The business’s 50-day simple moving average is $99.15 and its 200-day simple moving average is $103.21. The company has a market cap of $26.28 billion, a P/E ratio of 47.96, a PEG ratio of 1.14 and a beta of 0.61. Cardinal Health has a one year low of $85.11 and a one year high of $116.04.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Wednesday, August 14th. The company reported $1.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.74 by $0.10. The firm had revenue of $59.87 billion for the quarter, compared to the consensus estimate of $58.74 billion. Cardinal Health had a negative return on equity of 54.74% and a net margin of 0.25%. The firm’s quarterly revenue was up 12.1% compared to the same quarter last year. During the same quarter last year, the business posted $1.55 EPS. As a group, analysts predict that Cardinal Health will post 7.35 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

CAH has been the topic of a number of research reports. Argus dropped their price target on Cardinal Health from $120.00 to $115.00 and set a buy rating on the stock in a research note on Wednesday, May 15th. UBS Group raised their price target on Cardinal Health from $120.00 to $125.00 and gave the stock a buy rating in a research note on Thursday. Evercore ISI lifted their target price on Cardinal Health from $105.00 to $115.00 and gave the company an in-line rating in a research note on Thursday. Wells Fargo & Company lifted their target price on Cardinal Health from $95.00 to $101.00 and gave the company an underweight rating in a research note on Thursday. Finally, StockNews.com downgraded Cardinal Health from a strong-buy rating to a buy rating in a research note on Thursday, August 8th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of Moderate Buy and a consensus target price of $113.25.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.